[go: up one dir, main page]

ES2160727T3 - Parches medicinales para administracion percutanea. - Google Patents

Parches medicinales para administracion percutanea.

Info

Publication number
ES2160727T3
ES2160727T3 ES95941909T ES95941909T ES2160727T3 ES 2160727 T3 ES2160727 T3 ES 2160727T3 ES 95941909 T ES95941909 T ES 95941909T ES 95941909 T ES95941909 T ES 95941909T ES 2160727 T3 ES2160727 T3 ES 2160727T3
Authority
ES
Spain
Prior art keywords
penetration
skin
potentiator
water absorption
capacity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95941909T
Other languages
English (en)
Inventor
Jung Ju Kim
Woo Hyun Bae
Yoo Chul Lee
Yang Gyu Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacific Pharmaceutical Co Ltd
Pacific Corp
Original Assignee
Pacific Pharmaceutical Co Ltd
Pacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019950053707A external-priority patent/KR100188180B1/ko
Application filed by Pacific Pharmaceutical Co Ltd, Pacific Corp filed Critical Pacific Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2160727T3 publication Critical patent/ES2160727T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE MUESTRA UN PARCHE CUTANEO TRANSDERMICO PARA ADHERIR A LA PIEL DEL PACIENTE QUE CONSISTE DE UNA CAPA SUPERIOR IMPERMEABLE AL AGUA, UNA CUBIERTA Y, ENTRE LAS DOS, UNA CAPA MULTIPLE LAMINADA FORMADA POR 2 A 5 CAPAS ADHESIVAS, CADA UNA DE LAS CUALES CONTIENE UN INGREDIENTE ACTIVO, UNA RESINA ADHESIVA Y UN POTENCIADOR DE PENETRACION. NINGUNA DE LAS CAPAS CONTIENE AGUA Y CADA UNA DE ELLAS TIENE UNA CAPACIDAD DISTINTA DE ABSORCION DE AGUA: LA CAPA INFERIOR, QUE ENTRARA EN CONTACTO CON LA PIEL, TIENE LA MENOR CAPACIDAD DE ABSORCION DE AGUA, Y LA CAPA SUPERIOR, EN CONTACTO CON LA CAPA IMPERMEABLE, TIENE LA MAYOR CAPACIDAD DE ABSORCION DE AGUA. EL POTENCIADOR DE PENETRACION MENCIONADO ES HEXILENGLICOL, PRESENTE EN UNA CANTIDAD DE 0,5 A 40% POR PESO. EL PARCHE DE LA PRESENTE INVENCION CONTIENE HEXILENGLICOL COMO POTENCIADOR DE PENETRACION, QUE PERMITE POTENCIAR DE MANERA EFICAZ LA PENETRACION DEL INGREDIENTE ACTIVO A TRAVES DE LA PIEL, Y AL MISMO TIEMPO ES SEGURO PARA SU APLICACION CUTANEA.
ES95941909T 1994-12-24 1995-12-23 Parches medicinales para administracion percutanea. Expired - Lifetime ES2160727T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19940036654 1994-12-24
KR1019950053707A KR100188180B1 (ko) 1994-12-24 1995-12-21 경피투여용 패취제제

Publications (1)

Publication Number Publication Date
ES2160727T3 true ES2160727T3 (es) 2001-11-16

Family

ID=26630794

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95941909T Expired - Lifetime ES2160727T3 (es) 1994-12-24 1995-12-23 Parches medicinales para administracion percutanea.

Country Status (5)

Country Link
EP (1) EP0746311B1 (es)
CN (1) CN1057906C (es)
CA (1) CA2183960E (es)
ES (1) ES2160727T3 (es)
WO (1) WO1996019976A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191834T3 (es) * 1996-10-24 2003-09-16 Alza Corp Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
ID23512A (id) * 1997-04-16 2000-04-27 Hisamitsu Pharmaceutical Co Komposisi dasar untuk penyerapan melalui kulit dan sediaan yang dapat diserap melalui kulit yang mengandung komposisi dasar
DE19834007C1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
DE19925613A1 (de) * 1999-06-04 2000-12-07 Lohmann Therapie Syst Lts Verbundlaminat und Verfahren zu seiner Herstellung
CA2437899C (en) 2001-02-13 2012-05-15 Gregory M. Glenn Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea
JP2004525921A (ja) * 2001-03-19 2004-08-26 イオマイ コーポレイシヨン 経皮免疫用パッチ
CN101420946B (zh) * 2006-04-11 2011-05-25 日绊株式会社 含有坦索罗辛的透皮吸收型制剂
JP5097034B2 (ja) * 2007-07-20 2012-12-12 日東電工株式会社 貼付剤および貼付製剤
EP2191833B1 (en) * 2007-09-20 2013-02-13 Shiseido Company, Ltd. Transdermally absorbable preparation
CN112206222A (zh) * 2018-11-09 2021-01-12 北京德默高科医药技术有限公司 含有布洛芬结构类似物的多层经皮给药系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs

Also Published As

Publication number Publication date
CA2183960E (en) 2001-08-21
EP0746311B1 (en) 2001-07-11
EP0746311A1 (en) 1996-12-11
CN1162260A (zh) 1997-10-15
CA2183960A1 (en) 1996-07-04
CN1057906C (zh) 2000-11-01
WO1996019976A1 (en) 1996-07-04
CA2183960C (en) 1999-07-27

Similar Documents

Publication Publication Date Title
ES2160727T3 (es) Parches medicinales para administracion percutanea.
ATE479413T1 (de) Gerät zur verhinderung und/oder heilung von druckgeschwüren
ES2152979T3 (es) Sistema terapeutico transdermal que contiene estradiol.
YU2694A (sh) Transdermalni terapeutski sistem za odavanje galantamina
AR064268A1 (es) Sistema terapeutico transdermico para administracion del principio activo buprenorfina
PT95002A (pt) Metodo e dispositivo para administracao transdermica de dexmedetomidina
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
AR021371A1 (es) Aposito
ES2068897T3 (es) Una sustancia biocompatible, tromborresistente que comprende hirudina, sus analogos o fragmentos, y metodos para producir la misma.
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
DE69326461D1 (de) Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
PE10197A1 (es) Articulo absorbente descartable con una zona de transferencia de humedad
ES2103271T3 (es) Dispositivo para administrar un agente activo a la piel o a mucosas.
ES2160623T3 (es) Composiciones farmaceuticas mejoradas para la penetracion en la piel de piroxicam.
AR026040A1 (es) Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel
ES2117152T3 (es) Sistema terapeutico percutaneo para la aplicacion de 17-beta-estradiol y procedimiento de fabricacion.
US3297032A (en) Adhesive bandage having container of medicament carried by removable protector strip
US20040161452A1 (en) Drug-dispensing dressing and composition for treating onychomycosis
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
ES2133405T3 (es) Sistema terapeutico percutaneo que contiene como sustancia activa 17-beta-estradiol (anhidro).
CA2480683A1 (en) Assembled unit consisting of individually separable transdermal therapeutic systems
FI900315A0 (fi) Saett att framstaella ett ytligt terapeutiskt system vilket innehaoller tillvaext av elakartade celler och tillvaextfoerhindrande aktivaemne, speciellt 5-fluoruracil.
ES2174492T3 (es) Sistema de administracion transdermica con escopolamina base como principio activo.
AR005011A1 (es) Articulo absorbente descartable con calce mejorado.
ES2138602T3 (es) Agente terapeutico para la amenaza de aborto.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 746311

Country of ref document: ES